Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SRPT

Sarepta Therapeutics Inc

May 05 • 04:00PM ET

21.79

-0.25 -1.13 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: VRTX BMRN ALNY IONS PFE PTCT EXEL PRTA BLUE RDUS

| Held by: IJR FBT XBI VTI VB VBK VXF SPSM IBB IJT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.44	Insider Own	5.27%	Shs Outstand	104.96M	Perf Week	3.42%
Market Cap	2.29B	Forward P/E	17.91	EPS next Y	1.22	Insider Trans	-0.37%	Shs Float	99.45M	Perf Month	-4.43%
Enterprise Value	2.39B	PEG	-	EPS next Q	0.98	Inst Own	87.80%	Short Float	25.47%	Perf Quarter	7.45%
Income	-842.79M	P/S	1.04	EPS this Y	142.13%	Inst Trans	-0.71%	Short Ratio	9.02	Perf Half Y	-9.25%
Sales	2.20B	P/B	2.01	EPS next Y	-59.49%	ROA	-23.05%	Short Interest	25.33M	Perf YTD	1.25%
Book/sh	10.87	P/C	2.43	EPS next 5Y	-	ROE	-63.17%	52W High	64.80 -66.37%	Perf Year	-65.77%
Cash/sh	8.95	P/FCF	-	EPS past 3/5Y	3.92% -0.05%	ROIC	-38.86%	52W Low	10.41 109.22%	Perf 3Y	-83.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	33.06% 32.41%	Gross Margin	59.56%	Volatility	4.37% 4.83%	Perf 5Y	-70.06%
Dividend TTM	-	EV/Sales	1.09	EPS Y/Y TTM	-438.50%	Oper. Margin	-29.92%	ATR (14)	1.08	Perf 10Y	30.01%
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	15.58%	Profit Margin	-38.34%	RSI (14)	56.51	Recom	2.74
Dividend Gr. 3/5Y	- -	Current Ratio	2.32	EPS Q/Q	-344.01%	SMA20	2.28%	Beta	0.25	Target Price	22.46
Payout	-	Debt/Eq	0.91	Sales Q/Q	-32.73%	SMA50	10.74%	Rel Volume	0.77	Prev Close	22.04
Employees	835	LT Debt/Eq	0.90	Earnings	May 06 AMC	SMA200	10.36%	Avg Volume	2.81M	Price	21.79
IPO	Jun 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	-228.27% 19.84%	Trades		Volume	2,157,254	Change	-1.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)